Sam-A Pharm. Co. Ltd
009300 | KO
Overview
Corporate Details
- ISIN(s):
- KR7009300005
- LEI:
- Country:
- South Korea
- Address:
- 강원도 원주시 문막읍 동화공단로 49, 원주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-25 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 30.7 KB | ||
| 2025-08-25 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 39.1 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 998.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 1009.9 KB | ||
| 2025-05-13 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 993.0 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.8 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 24.4 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.5 MB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 24.5 KB | ||
| 2025-03-17 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 110.0 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 112.4 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.2 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.1 KB | ||
| 2025-02-26 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.5 KB | ||
| 2024-12-10 00:00 |
Quarterly Report
[기재정정]분기보고서 (2024.09)
|
Korean | 902.6 KB |
Automate Your Workflow. Get a real-time feed of all Sam-A Pharm. Co. Ltd filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Sam-A Pharm. Co. Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sam-A Pharm. Co. Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea
028300
South Korea
028300
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea
067630
South Korea
067630
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea
196300
South Korea
196300
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea
047920
South Korea
047920
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
South Korea
115450
South Korea
115450
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark
HLUN
Denmark
HLUN
South Korea
145020
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America
HUMA
United States of America
HUMA
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea
205470
South Korea
205470
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea
200670
South Korea
200670